Clearmind Medicine Inc. (NASDAQ:CMND) Sees Large Growth in Short Interest

Clearmind Medicine Inc. (NASDAQ:CMND) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 620,700 shares, an increase of 453.7% from the December 15th total of 112,100 shares. Based on an average daily trading volume, of 1,140,000 shares, the short-interest ratio is currently 0.5 days. Currently, 21.0% of the company’s shares are short sold.

Clearmind Medicine Stock Down 1.4 %

Clearmind Medicine stock traded down $0.02 during trading on Tuesday, hitting $1.51. The company had a trading volume of 85,128 shares, compared to its average volume of 374,053. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.01. Clearmind Medicine has a 1-year low of $0.92 and a 1-year high of $2.30. The company’s 50 day simple moving average is $1.40 and its 200-day simple moving average is $1.41.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.